Keeping Inmates Safe with Beckman Coulter’s $4 Lab-based COVID Antigen Test

Prisons are very vulnerable to COVID-19 spread for a variety of reasons, including close-quarter living, poor health, overcrowding and limited access to quality of healthcare. We need affordable, reliable, routine and widely available testing to find and isolate infected individuals.

Beckman Coulter’s new lab-based antigen test is offered at $4, making reliable and frequent mass testing affordable in prisons where the exposure rate is high. Labs can run up to 200 tests per hour, and get results in 30 minutes or less. Up to 25 million tests per month are available for purchase.

Find out more about our $4 COVID-19 antigen test: www.beckmancoulter.com/antigen

#COVID19 #COVID #coronavirus #Antigen #AntigenTest #COVIDtest #vaccine #masstesting #Beckman #BeckmanCoulter #Communities #KeepCommunitiesSafe #Prisons #Inmates

About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place. For more information, please visit www.beckmancoulter.com.